NTAP
54
-2
MA
55
-9
MDT
59
-3
BAX
35
-4
DLTR
24
2
PRGO
39
3
KLAC
45
-5
SPG
53
-3
IVZ
46
-6
CMA
55
-3
DGX
43
-3
TAP
44
-3
LRCX
43
-6
GPC
25
-2
GS
59
-4
HCA
50
2
EL
25
-14
MTB
59
-4
GM
72
6
JPM
60
-3
NTAP
54
-2
MA
55
-9
MDT
59
-3
BAX
35
-4
DLTR
24
2
PRGO
39
3
KLAC
45
-5
SPG
53
-3
IVZ
46
-6
CMA
55
-3
DGX
43
-3
TAP
44
-3
LRCX
43
-6
GPC
25
-2
GS
59
-4
HCA
50
2
EL
25
-14
MTB
59
-4
GM
72
6
JPM
60
-3
Financhill
Back

Greenfire Resources Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
49

GFR
Greenfire Resources

Last Price:
7.11
Seasonality Move:
1.49%
Buy
71

MDGL
Madrigal Pharmaceuticals

Last Price:
305.95
Seasonality Move:
31.67%
Sell
49
Greenfire Resources (GFR) is a Sell

Is Greenfire Resources a Buy, Sell or Hold?

  • The current Greenfire Resources [GFR] share price is $7.10. The Score for GFR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • GFR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GFR Stock Price Chart

What is Greenfire Resources's stock price today?

  • The Greenfire Resources share price today is $7.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GFR is experiencing slight selling pressure.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $259.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

GFR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 40.44 Sell
Chaikin Money Flow: -10812 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.14 - 7.76) Sell
Bollinger Bands (100): (6.51 - 7.61) Buy

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 74.74 Buy
Chaikin Money Flow: 898979 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (203.29 - 223.91) Buy
Bollinger Bands (100): (221.8 - 277.54) Buy

GFR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.11 Sell
20-day SMA: 7.44 Sell
50-day SMA: 7.32 Sell
200-day SMA: 6.4 Buy
8-day EMA: 7.16 Sell
20-day EMA: 7.3 Sell
50-day EMA: 7.26 Sell
200-day EMA: 6.62 Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 216.22 Buy
20-day SMA: 214.16 Buy
50-day SMA: 227.04 Buy
200-day SMA: 240.71 Buy
8-day EMA: 223.2 Buy
20-day EMA: 218.42 Buy
50-day EMA: 226.38 Buy
200-day EMA: 233.63 Buy

Greenfire Resources Earnings Growth & GFR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.49 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.

Greenfire Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):